Characterization of hyperthyroidism enhancement of halothane-induced hepatotoxicity.
Administration of anesthetic doses of halothane to hyperthyroid male rats results in the development of hepatic necrosis. The severity of the hepatic lesion was dependent on the dose of triiodothyronine (T3) and the length of time it was administered. Pretreatment of rats with iodinated metabolites of thyroxin which do not induce hyperthyroidism did not result in any signs of hepatotoxicity after halothane exposure. The administration of halothane to hyperthyroid female rats or mice of either sex did not result in the development of any overt hepatotoxicity. Likewise, hyperthyroidism did not enhance the hepatotoxicity of another hepatotoxin bromobenzene. The in vitro enzymatic activities associated with cytochrome P-450-dependent metabolism and glutathione S-transferase conjugation activity were markedly altered in hyperthyroid rats. Cytochrome P-450 levels, aminopyrine N-demethylase activity, glutathione levels and glutathione S-transferase activity were all significantly lower in hyperthyroid rats. However, other enzyme activities were stimulated by T3 pretreatment; aniline hydroxylase activity was increased by 45% and cytochrome c reductase activity was increased by 54% in hyperthyroid rats. Glutathione levels were also reduced significantly in hyperthyroid male rats. Maximal changes in both the cytochrome P-450 system and in the glutathione detoxification system were required before halothane demonstrated its hepatotoxic effects. Thus, a new balance between cytochrome P-450-dependent bioactivation and glutathione conjugation of halothane may be necessary for the exaggerated hepatotoxicity of halothane seen in hyperthyroid male rats.
D000410:Alanine Transaminase / Q000097:blood; D000818:Animals; D001711:Biotransformation; D001969:Bromobenzenes / Q000633:toxicity; D056486:Chemical and Drug Induced Liver Injury / Q000378:metabolism* / Q000473:pathology; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism; D005260:Female; D006221:Halothane / Q000378:metabolism / Q000633:toxicity*; D006980:Hyperthyroidism / Q000378:metabolism*; D008297:Male; D051379:Mice; D009336:Necrosis / Q000139:chemically induced; D051381:Rats; D012737:Sex Factors; D013045:Species Specificity; D013217:Starvation / Q000378:metabolism; D013997:Time Factors; D014284:Triiodothyronine / Q000031:analogs & derivatives / Q000494:pharmacology
D001969:Bromobenzenes; D014284:Triiodothyronine; C032036:bromobenzene; D000410:Alanine Transaminase; D006221:Halothane